{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:20:08Z","timestamp":1775600408353,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J NeuroEngineering Rehabil"],"DOI":"10.1186\/s12984-024-01477-9","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T03:49:10Z","timestamp":1729136950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acceptability, validity and responsiveness of inertial measurement units for assessing motor recovery after gene therapy in infants with early onset spinal muscular atrophy: a prospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"R.","family":"Barrois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Tervil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cacioppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barnerias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Deladri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Leloup-Germa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Oudre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vayatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Quijano","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gitiaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Desguerre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"4","key":"1477_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346.","journal-title":"Neurol Clin"},{"issue":"7","key":"1477_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","volume":"25","author":"R Finkel","year":"2015","unstructured":"Finkel R, Bertini E, Muntoni F, Mercuri E. 209th ENMC International Workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7\u20139 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord. 2015;25(7):593\u2013602.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1477_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol mai. 2012;11(5):443\u201352.","journal-title":"Lancet Neurol mai"},{"issue":"3","key":"1477_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","volume":"28","author":"M Calucho","year":"2018","unstructured":"Calucho M, Bernal S, Al\u00edas L, March F, Vencesl\u00e1 A, Rodr\u00edguez-\u00c1lvarez FJ, et al. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord NMD. 2018;28(3):208\u201315.","journal-title":"Neuromuscul Disord NMD"},{"issue":"2","key":"1477_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70(2):358\u201368.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"1477_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40263-022-00941-1","volume":"36","author":"HA Blair","year":"2022","unstructured":"Blair HA. Onasemnogene abeparvovec: a review in spinal muscular atrophy. CNS Drugs. 2022;36(9):995\u20131005.","journal-title":"CNS Drugs"},{"issue":"18","key":"1477_CR7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N Engl J Med. 2017;377(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"1477_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2352-4642(21)00287-X","volume":"6","author":"C Wei\u00df","year":"2022","unstructured":"Wei\u00df C, Ziegler A, Becker LL, Johannsen J, Brennenstuhl H, Schreiber G, et al. Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study. Lancet Child Adolesc Health. 2022;6(1):17\u201327.","journal-title":"Lancet Child Adolesc Health."},{"issue":"4","key":"1477_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day JW, Finkel RS, Chiriboga CA, Connolly AM, Crawford TO, Darras BT, et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 2021;20(4):284\u201393.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1477_CR10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0729","volume":"146","author":"MA Waldrop","year":"2020","unstructured":"Waldrop MA, Karingada C, Storey MA, Powers B, Iammarino MA, Miller NF, et al. Gene therapy for spinal muscular atrophy: safety and early outcomes. Pediatrics. 2020;146(3): e20200729.","journal-title":"Pediatrics"},{"issue":"10","key":"1477_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S1474-4422(21)00251-9","volume":"20","author":"E Mercuri","year":"2021","unstructured":"Mercuri E, Muntoni F, Baranello G, Masson R, Boespflug-Tanguy O, Bruno C, et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 2021;20(10):832\u201341.","journal-title":"Lancet Neurol"},{"key":"1477_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12883-023-03133-6","volume":"23","author":"GM Stettner","year":"2023","unstructured":"Stettner GM, Hasselmann O, Tscherter A, Galiart E, Jacquier D, Klein A. Treatment of spinal muscular atrophy with onasemnogene abeparvovec in Switzerland: a prospective observational case series study. BMC Neurol. 2023;23:88.","journal-title":"BMC Neurol"},{"issue":"7\u20138","key":"1477_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41434-022-00341-6","volume":"30","author":"I Bitetti","year":"2023","unstructured":"Bitetti I, Lanzara V, Margiotta G, Varone A. Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational study. Gene Ther. 2023;30(7\u20138):592\u20137.","journal-title":"Gene Ther"},{"key":"1477_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2022.04.006","volume":"39","author":"J Erdos","year":"2022","unstructured":"Erdos J, Wild C. Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic review of real-world study data. Eur J Paediatr Neurol. 2022;39:1\u201310.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1477_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","volume":"20","author":"AM Glanzman","year":"2010","unstructured":"Glanzman AM, Mazzone E, Main M, Pelliccioni M, Wood J, Swoboda KJ, et al. The Children\u2019s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. Neuromuscul Disord. 2010;20(3):155\u201361.","journal-title":"Neuromuscul Disord"},{"key":"1477_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"1477_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JND-180315","volume":"5","author":"A Pechmann","year":"2018","unstructured":"Pechmann A, Langer T, Schorling D, Stein S, Vogt S, Schara U, et al. Evaluation of children with SMA type 1 under treatment with nusinersen within the expanded access program in Germany. J Neuromuscul Dis. 2018;5(2):135\u201343.","journal-title":"J Neuromuscul Dis"},{"issue":"7","key":"1477_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.nmd.2018.05.010","volume":"28","author":"M Pane","year":"2018","unstructured":"Pane M, Palermo C, Messina S, Sansone VA, Bruno C, Catteruccia M, et al. Nusinersen in type 1 SMA infants, children and young adults: preliminary results on motor function. Neuromuscul Disord. 2018;28(7):582\u20135.","journal-title":"Neuromuscul Disord"},{"key":"1477_CR19","unstructured":"Bayley N. Manual for the Bayley scales of infant development. Psychological Corporation; 1969."},{"issue":"2","key":"1477_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"1477_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000477383","volume":"1","author":"ER Dorsey","year":"2017","unstructured":"Dorsey ER, Papapetropoulos S, Xiong M, Kieburtz K. The first frontier: digital biomarkers for neurodegenerative disorders. Digit Biomark. 2017;1(1):6\u201313.","journal-title":"Digit Biomark."},{"key":"1477_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelekin.2020.102481","volume":"55","author":"M Cacioppo","year":"2020","unstructured":"Cacioppo M, Marin A, Rauscent H, Le Pabic E, Gaillard F, Brochard S, et al. A new child-friendly 3D bimanual protocol to assess upper limb movement in children with unilateral cerebral palsy: Development and validation. J Electromyogr Kinesiol Off J Int Soc Electrophysiol Kinesiol. 2020;55: 102481.","journal-title":"J Electromyogr Kinesiol Off J Int Soc Electrophysiol Kinesiol."},{"issue":"4","key":"1477_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.gaitpost.2009.07.110","volume":"30","author":"E Jaspers","year":"2009","unstructured":"Jaspers E, Desloovere K, Bruyninckx H, Molenaers G, Klingels K, Feys H. Review of quantitative measurements of upper limb movements in hemiplegic cerebral palsy. Gait Posture. 2009;30(4):395\u2013404.","journal-title":"Gait Posture"},{"issue":"12","key":"1477_CR24","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/s16122134","volume":"16","author":"H Chen","year":"2016","unstructured":"Chen H, Xue M, Mei Z, Bambang Oetomo S, Chen W. A review of wearable sensor systems for monitoring body movements of neonates. Sensors. 2016;16(12):2134.","journal-title":"Sensors"},{"key":"1477_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.earlhumdev.2019.01.002","volume":"130","author":"CS Bultmann","year":"2019","unstructured":"Bultmann CS, Orlikowsky T, H\u00e4usler M, Trepels-Kottek S, Disselhorst-Klug C, Schoberer M. Spontaneous movements in the first four months of life: an accelerometric study in moderate and late preterm infants. Early Hum Dev mars. 2019;130:1\u20139.","journal-title":"Early Hum Dev mars"},{"key":"1477_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01942638.2023.2218478","volume":"44","author":"CH Verhage","year":"2023","unstructured":"Verhage CH, Gorter JW, Takken T, Benders MJNL, de Vries LS, van der Aa NE, et al. Detecting asymmetry of upper limb activity with accelerometry in infants at risk for unilateral spastic cerebral palsy. Phys Occup Ther Pediatr. 2023;44:1\u201315.","journal-title":"Phys Occup Ther Pediatr"},{"issue":"11","key":"1477_CR27","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/oby.2011.364","volume":"20","author":"SG Trost","year":"2012","unstructured":"Trost SG, Fees BS, Haar SJ, Murray AD, Crowe LK. Identification and validity of accelerometer cut-points for toddlers. Obes Silver Spring Md. 2012;20(11):2317\u20139.","journal-title":"Obes Silver Spring Md"},{"key":"1477_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12984-023-01182-z","volume":"20","author":"M Franchi de\u2019 Cavalieri","year":"2023","unstructured":"Franchi de\u2019 Cavalieri M, Filogna S, Martini G, Beani E, Maselli M, Cianchetti M, et al. Wearable accelerometers for measuring and monitoring the motor behaviour of infants with brain damage during CareToy-Revised training. J NeuroEngineering Rehabil. 2023;20:62.","journal-title":"J NeuroEngineering Rehabil."},{"key":"1477_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3389\/fpsyg.2017.00817","volume":"8","author":"A Vienne","year":"2017","unstructured":"Vienne A, Barrois RP, Buffat S, Ricard D, Vidal PP. Inertial sensors to assess gait quality in patients with neurological disorders: a systematic review of technical and analytical challenges. Front Psychol. 2017;8:817.","journal-title":"Front Psychol"},{"issue":"6","key":"1477_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156696","volume":"11","author":"AG Le Moing","year":"2016","unstructured":"Le Moing AG, Seferian AM, Moraux A, Annoussamy M, Dorveaux E, Gasnier E, et al. A movement monitor based on magneto-inertial sensors for non-ambulant patients with Duchenne muscular dystrophy: a pilot study in controlled environment. PLoS ONE. 2016;11(6): e0156696.","journal-title":"PLoS ONE"},{"issue":"7","key":"1477_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201004","volume":"13","author":"A Chabanon","year":"2018","unstructured":"Chabanon A, Seferian AM, Daron A, P\u00e9r\u00e9on Y, Cances C, Vuillerot C, et al. Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS ONE. 2018;13(7): e0201004.","journal-title":"PLoS ONE"},{"key":"1477_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2023.104549","volume":"139","author":"R Bard-Pondarr\u00e9","year":"2023","unstructured":"Bard-Pondarr\u00e9 R, Al-Abiad N, Verdun S, Naa\u00efm A, Agopyan H, Chal\u00e9at-Valayer E, et al. Does accelerometry reflect hand function in infants at risk of unilateral cerebral palsy? A secondary analysis of BB-Bim results. Res Dev Disabil. 2023;139: 104549.","journal-title":"Res Dev Disabil"},{"key":"1477_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2022.105685","volume":"174","author":"LA Jardine","year":"2022","unstructured":"Jardine LA, Mausling RM, Caldararo D, Colditz PW, Davies MW. Accelerometer measures in extremely preterm and or extremely low birth weight infants and association with abnormal general movements assessments at 28- and 32-weeks postmenstrual age. Early Hum Dev. 2022;174: 105685.","journal-title":"Early Hum Dev"},{"issue":"13","key":"1477_CR34","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.3390\/s19132886","volume":"19","author":"J Zhou","year":"2019","unstructured":"Zhou J, Schaefer SY, Smith BA. Quantifying caregiver movement when measuring infant movement across a full day: a case report. Sensors. 2019;19(13):2886.","journal-title":"Sensors"},{"issue":"1","key":"1477_CR35","doi-asserted-by":"publisher","first-page":"11958","DOI":"10.1038\/s41598-022-16003-x","volume":"12","author":"A Neishabouri","year":"2022","unstructured":"Neishabouri A, Nguyen J, Samuelsson J, Guthrie T, Biggs M, Wyatt J, et al. Quantification of acceleration as activity counts in ActiGraph wearable. Sci Rep. 2022;12(1):11958.","journal-title":"Sci Rep"},{"issue":"12","key":"1477_CR36","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1249\/MSS.0b013e3181aa3a0e","volume":"41","author":"CA Howe","year":"2009","unstructured":"Howe CA, Staudenmayer JW, Freedson PS. Accelerometer prediction of energy expenditure: vector magnitude versus vertical axis. Med Sci Sports Exerc. 2009;41(12):2199\u2013206.","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"1477_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/02640414.2021.1994726","volume":"40","author":"TM Altenburg","year":"2022","unstructured":"Altenburg TM, de Vries L, Op den Buijsch R, Eyre E, Dobell A, Duncan M, et al. Cross-validation of cut-points in preschool children using different accelerometer placements and data axes. J Sports Sci. 2022;40(4):379\u201385.","journal-title":"J Sports Sci"},{"issue":"2","key":"1477_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/JND-210743","volume":"9","author":"L Servais","year":"2022","unstructured":"Servais L, Yen K, Guridi M, Lukawy J, Vissi\u00e8re D, Strijbos P. Stride Velocity 95th Centile: insights into gaining regulatory qualification of the first wearable-derived digital endpoint for use in Duchenne Muscular Dystrophy Trials. J Neuromuscul Dis. 2022;9(2):335\u201346.","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"1477_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.nmd.2023.02.004","volume":"33","author":"R Barrois","year":"2023","unstructured":"Barrois R, Barnerias C, Deladri\u00e8re E, Leloup-Germa V, Tervil B, Audic F, et al. A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy. Neuromuscul Disord. 2023;33(4):309\u201314.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1477_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/bjpt-rbf.2014.0143","volume":"20","author":"LB Mokkink","year":"2016","unstructured":"Mokkink LB, Prinsen CA, Bouter LM, de Vet HC, Terwee CB. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument. Braz J Phys Ther. 2016;20(2):105\u201313.","journal-title":"Braz J Phys Ther"},{"issue":"7","key":"1477_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737\u201345.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1477_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12966-017-0633-5","volume":"14","author":"A Prioreschi","year":"2017","unstructured":"Prioreschi A, Brage S, Hesketh KD, Hnatiuk J, Westgate K, Micklesfield LK. Describing objectively measured physical activity levels, patterns, and correlates in a cross sectional sample of infants and toddlers from South Africa. Int J Behav Nutr Phys Act. 2017;14(1):176.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"1","key":"1477_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12966-020-0912-4","volume":"17","author":"BA Bruijns","year":"2020","unstructured":"Bruijns BA, Truelove S, Johnson AM, Gilliland J, Tucker P. Infants\u2019 and toddlers\u2019 physical activity and sedentary time as measured by accelerometry: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2020;17(1):14.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"1","key":"1477_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/1099800410378889","volume":"13","author":"SY Tsai","year":"2011","unstructured":"Tsai SY, Barnard KE, Lentz MJ, Thomas KA. Mother-infant activity synchrony as a correlate of the emergence of circadian rhythm. Biol Res Nurs. 2011;13(1):80\u20138.","journal-title":"Biol Res Nurs"},{"issue":"6","key":"1477_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1123\/jpah.2016-0395","volume":"14","author":"EA Pitchford","year":"2017","unstructured":"Pitchford EA, Ketcheson LR, Kwon HJ, Ulrich DA. Minimum accelerometer wear time in infants: a generalizability study. J Phys Act Health. 2017;14(6):421\u20138.","journal-title":"J Phys Act Health"},{"issue":"10","key":"1477_CR46","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s10995-018-2614-y","volume":"22","author":"Z Jia","year":"2018","unstructured":"Jia Z, Zhang J, Trindade D, Sobko T. Physical activity patterns and correlates of 9-month-old Chinese infants in the Macau population. Matern Child Health J. 2018;22(10):1526\u201333.","journal-title":"Matern Child Health J"},{"key":"1477_CR47","unstructured":"Qualification opinion on stride velocity 95th centile as a secondary endpoint in Duchenne Muscular Dystrophy measured by a valid and suitable wearable device."}],"container-title":["Journal of NeuroEngineering and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12984-024-01477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12984-024-01477-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12984-024-01477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T15:04:56Z","timestamp":1729177496000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroengrehab.biomedcentral.com\/articles\/10.1186\/s12984-024-01477-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1186\/s12984-024-01477-9","relation":{},"ISSN":["1743-0003"],"issn-type":[{"value":"1743-0003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered on clinical trial (NCT04833348). The study protocol was approved by a national ethical review boards (Comit\u00e9 de Protection des Personnes [Ref protocol CNRIPH: 20.12.29.48438 \u2013 IMUSMA study]) and study procedures were conducted according to the principles outlined in the Declaration of Helsinki. All parents or guardians provided written informed consent after thorough explanations of the study goals and procedures were given.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors provided their consent for publication of the present version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}